Literature DB >> 19121256

25-year-old man with flank pain, hematuria, and proteinuria.

Andrew Smyth1, Vesna D Garovic.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19121256      PMCID： PMC2664573          DOI： 10.1016/S0025-6196(11)60810-0

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  11 in total

1.  Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.

Authors:  Ellen M Ginzler; Mary Anne Dooley; Cynthia Aranow; Mimi Y Kim; Jill Buyon; Joan T Merrill; Michelle Petri; Gary S Gilkeson; Daniel J Wallace; Michael H Weisman; Gerald B Appel
Journal:  N Engl J Med       Date:  2005-11-24       Impact factor: 91.245

2.  [Interstitial nephritis attributed to treatment with piperacillin-tazobactam and with ciprofloxacin].

Authors:  L Mannaerts; A A Van der Wurff; F H J Wolfhagen
Journal:  Ned Tijdschr Geneeskd       Date:  2006-04-08

3.  Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.

Authors:  Mikkel Faurschou; Henrik Starklint; Poul Halberg; Søren Jacobsen
Journal:  J Rheumatol       Date:  2006-08       Impact factor: 4.666

4.  Prevention of nephrotoxicity induced by radiocontrast agents.

Authors:  B J Barrett; P S Parfrey
Journal:  N Engl J Med       Date:  1994-11-24       Impact factor: 91.245

Review 5.  Rituximab: a promising therapy in systemic lupus erythematosus.

Authors:  Akaluck Thatayatikom; Andrew J White
Journal:  Autoimmun Rev       Date:  2005-06-13       Impact factor: 9.754

6.  Lupus membranous nephropathy: long-term outcome.

Authors:  S Pasquali; G Banfi; A Zucchelli; G Moroni; C Ponticelli; P Zucchelli
Journal:  Clin Nephrol       Date:  1993-04       Impact factor: 0.975

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

Review 8.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

9.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

10.  Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease.

Authors:  Miho Kimura; Sumiaki Tanaka; Akira Ishikawa; Hirahito Endo; Shunsei Hirohata; Hirobumi Kondo
Journal:  Rheumatol Int       Date:  2007-12-14       Impact factor: 3.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.